Liabilities / Assets
75th percentile
Higher debt load relative to assets than 75% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
75th percentile
Higher debt load relative to assets than 75% of similar nonprofits.
Liabilities / Revenue
70th percentile
Higher debt load relative to revenue than 70% of similar nonprofits.
Net Margin
32nd percentile
Higher net margin than 32% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
24th percentile
Faster asset growth than 24% of similar nonprofits.
Revenue Growth
60th percentile
Faster revenue growth than 60% of similar nonprofits.
Assets
Down$114,823
Down $20,683 (-15%) from 2016
Net Assets
Down$106,694
Down $5,607 (-5.0%) from 2016
Liabilities
Down$8,128
Down $15,077 (-65%) from 2016
Revenue
Up$381,458
Up $28,558 (+8.1%) from 2016
Expenses
Down$396,581
Down $50,938 (-11%) from 2016
Net Income
Up-$15,123
Up $79,496 (+84%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To provide and facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues that affect the mind, body, and culture. Erowid Center supports and trains libraries, publishers, and other information distributors on issues related to our field. Further, it is Erowid Center's goal to support medical, legal, scientific, academic, and independent experts in developing and publishing related resources.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.